Dr. Paul Swiecicki
Claim this profileUniversity of Michigan Comprehensive Cancer Center
Studies Melanoma
Studies Squamous Cell Carcinoma
19 reported clinical trials
29 drugs studied
Area of expertise
1Melanoma
metastatic
Stage IV
locally advanced
2Squamous Cell Carcinoma
Stage IV
metastatic
locally advanced
Affiliated Hospitals
Clinical Trials Paul Swiecicki is currently running
Cyclophosphamide + Sirolimus
for Advanced Thyroid Cancer
This trial uses two drugs, Cyclophosphamide and Sirolimus, to treat patients with thyroid cancer that has spread. Cyclophosphamide kills cancer cells by breaking their DNA, while Sirolimus stops them from growing. Sirolimus has been used in various treatments and has shown effectiveness against different cancers. Patients are monitored for side effects and effectiveness.
Recruiting1 award Phase 211 criteria
CDR404
for Cancer
CDR404 is a highly potent and specific T-cell engaging bispecific and bivalent antibody designed for the treatment of cancers positive for the tumor-associated antigen melanoma-associated antigen 4 (MAGE-A4). This is a first-in-human study designed to evaluate the safety, tolerability, and preliminary anti-tumor activity of CDR404 in adult patients who have the appropriate germline human leukocyte antigen HLA-A\*02:01 tissue marker and whose cancer is positive for MAGE-A4.
Recruiting1 award Phase 14 criteria
More about Paul Swiecicki
Clinical Trial Related6 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Paul Swiecicki has experience with
- Carboplatin
- Pembrolizumab
- Cisplatin
- Docetaxel
- Intensity-Modulated Radiation Therapy
- Cyclophosphamide
Breakdown of trials Paul Swiecicki has run
Melanoma
Squamous Cell Carcinoma
Solid Tumors
Salivary Gland Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Swiecicki specialize in?
Paul Swiecicki focuses on Melanoma and Squamous Cell Carcinoma. In particular, much of their work with Melanoma has involved metastatic patients, or patients who are Stage IV.
Is Paul Swiecicki currently recruiting for clinical trials?
Yes, Paul Swiecicki is currently recruiting for 9 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Paul Swiecicki has studied deeply?
Yes, Paul Swiecicki has studied treatments such as Carboplatin, Pembrolizumab, Cisplatin.
What is the best way to schedule an appointment with Paul Swiecicki?
Apply for one of the trials that Paul Swiecicki is conducting.
What is the office address of Paul Swiecicki?
The office of Paul Swiecicki is located at: University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.